Evidence map›Paper›PMID 26874686›Full record

ArticleCellular and molecular life sciences : CMLS2016

Deep characterization of blood cell miRNomes by NGS.

Eva C Schwarz, Christina Backes, Arne Knörck, Nicole Ludwig, Petra Leidinger, Cora Hoxha, Gertrud Schwär, Thomas Grossmann, Sabine C Müller, Martin Hart and 10 more

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Big Strides in Cellular MicroRNA Expression.Trends in genetics : TIG · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes.International journal of molecular sciences · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Eva C SchwarzBiophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany.
Christina BackesSaarland University, Building E2.1, 66123, Saarbrücken, Germany. c.backes@mx.uni-saarland.de.
Arne KnörckBiophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany.
Nicole LudwigDepartment of Human Genetics, Saarland University, Homburg, Germany.
Petra LeidingerDepartment of Human Genetics, Saarland University, Homburg, Germany.
Cora HoxhaBiophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany.
Gertrud SchwärBiophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany.
Thomas GrossmannSaarland University, Building E2.1, 66123, Saarbrücken, Germany.
Sabine C MüllerSaarland University, Building E2.1, 66123, Saarbrücken, Germany.
Martin HartDepartment of Human Genetics, Saarland University, Homburg, Germany.
Jan HaasDepartment of Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany.
Valentina GalataSaarland University, Building E2.1, 66123, Saarbrücken, Germany.
Isabelle MüllerClinical Hemostaseology and Transfusion Medicine, Saarland University, Homburg, Germany.
Tobias FehlmannSaarland University, Building E2.1, 66123, Saarbrücken, Germany.
Hermann EichlerClinical Hemostaseology and Transfusion Medicine, Saarland University, Homburg, Germany.
Andre FrankeKiel University, Kiel, Germany.
Benjamin MederDepartment of Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany.
Eckart MeeseDepartment of Human Genetics, Saarland University, Homburg, Germany.
Markus HothBiophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany.
Andreas KellerSaarland University, Building E2.1, 66123, Saarbrücken, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A systematic understanding of different factors influencing cell type specific microRNA profiles is essential for state-of-the art biomarker research. We carried out a comprehensive analysis of the biological variability and changes in cell type pattern over time for different cell types and different isolation approaches in technical replicates. All combinations of the parameters mentioned above have been measured, resulting in 108 miRNA profiles that were evaluated by next-generation-sequencing. The largest miRNA variability was due to inter-individual differences (34 %), followed by the cell types (23.4 %) and the isolation technique (17.2 %). The change over time in cell miRNA composition was moderate (<3 %) being close to the technical variations (<1 %). Largest variability (including technical and biological variance) was observed for CD8 cells while CD3 and CD4 cells showed significantly lower variations. ANOVA highlighted that 51.5 % of all miRNAs were significantly influenced by the purification technique. While CD4 cells were least affected, especially miRNA profiles of CD8 cells were fluctuating depending on the cell purification approach. To provide researchers access to the profiles and to allow further analyses of the tested conditions we implemented a dynamic web resource.

Indexed as

Base SequenceBlood CellsCluster AnalysisGene Expression ProfilingHigh-Throughput Nucleotide SequencingHumansMicroRNAsPrincipal Component AnalysisMicroRNAsBlood cellsFACSmicroRNANext-generation sequencing

Identifiers

PMID26874686
PMCPMC11108270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.